cureVision
PrivateLast Round
Seed
Oct 7, 2025
Est. Valuation
$12.64M
Total Funding Raised
$4.09M
Company Overview
cureVision operates in Healthcare & Life Sciences and is based in Munich. Its latest recorded funding round was a Seed round in October 2025.
cureVision is a medical technology company that provides an AI-powered, all-in-one solution for the digital analysis, documentation, and management of chronic wounds.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical AI, Medical Imaging, Computer Vision
Business Model
B2B
Customer Profile
Hardware + Subscription, Hardware Sales, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
cureVision Comparables
Compare cureVision with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| KroniKare | 88% | |
| eKare Inc. | 86% | |
| Pixacare | 80% |
For institutional investors. Book with your work email.
cureVision Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Oct 7, 2025 | ||||
| Accelerator | Mar 28, 2024 | ||||
| Grant | Mar 23, 2023 | ||||
| Seed | Oct 18, 2022 |
For institutional investors. Book with your work email.
cureVision Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Investitionsbank des Landes Brandenburg | Seed |
| AQAL Group | Seed |
| Luminate Accelerator | Accelerator |
| Brandenburg Kapital | Seed |
| Companisto | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 22, 2026
Grew 17% QoQ, from 23 to 27 employees.
- Jan 1, 2026
Monthly visitors increased 65% MoM, reaching 1.2K.
For institutional investors. Book with your work email.
cureVision Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about cureVision's valuation, stock price, and market status.
Is cureVision a public or private company?
cureVision is a private company.
What is the current stock price of cureVision?
cureVision is a private company, so its shares have no public market price. Caplight tracks cureVision's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is cureVision worth (valuation)?
cureVision's valuation is estimated at $12.6M based on funding round data.
Can I buy cureVision stock?
cureVision shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was cureVision's last funding round?
cureVision's most recent funding round was Seed on October 7, 2025.
Who are the main investors in cureVision?
Key investors in cureVision include Luminate Accelerator.
Will cureVision IPO soon?
No public IPO plans have been announced for cureVision.
How can I track cureVision secondary market activity?
Caplight tracks bids, offers, and trades in cureVision's shares on secondary markets.